About Temoside Temozolomide 100 Mg Capsule, Cipla
Temoside Temozolomide 100 mg Capsule by Cipla is a must-have, transcendent addition to your oncology arsenal for chemotherapy. Each polished, hard gelatin capsule contains 100 mg of Temozolomide, meticulously formulated for personalised and effective brain tumor management, including glioblastoma multiforme and anaplastic astrocytoma. Available internationally, this towering chemotherapeutic agent follows a strictly Rx-only regime, emphasizing safety and impactful cancer care. Avoid direct skin contact; handle with care. Store below 30C, protected from moisture. Each strip contains 5 capsules for optimal convenience. Shelf life is commonly 24 months or as specified on packaging.
Mode of Application, Highlights, and Target Areas
Temoside Temozolomide 100 mg Capsule is designed for oral administration, allowing for convenient and accurate dosing in the treatment of specific brain tumors. This chemotherapeutic agent is especially suitable for addressing conditions such as glioblastoma multiforme and anaplastic astrocytoma. Highlighted features include a prescription-only classification, cytotoxic anticancer activity, and a formulation by Cipla-renowned for quality and reliability. Use only as directed and under strict medical supervision.
Sample Policy, Packaging, and Certification Information
Quick Dispatch is assured with every supply of Temoside Temozolomide 100 mg Capsules. Each strip is securely packaged with five hard gelatin capsules per pack, maintaining product integrity and safety. Our transparent sample policy, reliable delivery system, and competitive list price enhance customer confidence. All products are certified according to regulatory standards, ensuring compliance for global distribution across countries such as Canada, UK, USA, EU, and Australia.
FAQ's of Temoside Temozolomide 100 Mg Capsule, Cipla:
Q: How should Temoside Temozolomide 100 mg Capsule be administered?
A: Temoside 100 mg is taken orally as directed by a healthcare professional, with the dose and duration tailored according to the patient's treatment plan.
Q: What types of cancers does Temoside 100 mg target?
A: This medication is primarily indicated for certain brain tumors, particularly glioblastoma multiforme and anaplastic astrocytoma, offering targeted chemotherapeutic action.
Q: When should I avoid direct contact with the capsule?
A: Handle Temoside capsules with care and avoid direct contact with the skin, as it is a cytotoxic agent. Always use appropriate precautions and safety tools when handling.
Q: Where is Temoside 100 mg available for purchase?
A: Temoside 100 mg is supplied and marketed in various countries, including Canada, the UK, EU, USA, and Australia, subject to prescription regulations.
Q: What storage conditions are recommended for Temoside 100 mg?
A: The capsules should be stored below 30C, protected from moisture, and kept in their original packaging to preserve stability and potency.
Q: How does using Temoside 100 mg benefit patients with brain tumors?
A: Temoside 100 mg provides a tailored chemotherapeutic approach, aiming to slow tumor growth and improve outcomes in brain tumor patients, under medical supervision.